| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | L-685458 | CCLE | pan-cancer | AAC | -0.1 | 0.03 |
| mRNA | PLX4720 | CCLE | pan-cancer | AAC | 0.098 | 0.04 |
| mRNA | Nilotinib | CCLE | pan-cancer | AAC | -0.11 | 0.04 |
| mRNA | PHA-665752 | CCLE | pan-cancer | AAC | -0.09 | 0.08 |
| mRNA | Sorafenib | CCLE | pan-cancer | AAC | -0.086 | 0.09 |
| mRNA | Vandetanib | CCLE | pan-cancer | AAC | -0.084 | 0.1 |
| mRNA | Topotecan | CCLE | pan-cancer | AAC | -0.073 | 0.1 |
| mRNA | Erlotinib | CCLE | pan-cancer | AAC | -0.069 | 0.2 |
| mRNA | AZD0530 | CCLE | pan-cancer | AAC | -0.071 | 0.2 |
| mRNA | LBW242 | CCLE | pan-cancer | AAC | -0.07 | 0.2 |